Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 4 Open-market sale Senior Vice President, R&D sold 2,500 shares at an average $28.01 ($70,025)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 8-K Event Other events
  8. 424B5 Offering Prospectus
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Results of operations · Other events
  13. 424B5 Offering Prospectus
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Open-market sale Chief Medical Officer sold 2,250 shares at an average $31.50 ($70,864)
  16. 4 Open-market sale Chief Commercial Officer sold 2,250 shares at an average $31.50 ($70,864)
  17. 4 Open-market sale Senior Vice President, R&D sold 4,500 shares at an average $31.50 ($141,728)
  18. 4 Open-market sale SVP, GC & Corporate Secretary sold 4,500 shares at an average $31.50 ($141,728)
  19. 4 Open-market sale Chief Financial Officer sold 4,500 shares at an average $31.50 ($141,728)
  20. 4 Open-market sale Chief Executive Officer sold 9,626 shares at an average $31.50 ($303,171)

Page 31 of 65 · 1,286 filings